openPR Logo
Press release

Market Research on Anesthesia Drugs Market 2016 and Analysis to 2020

12-22-2016 08:35 AM CET | Health & Medicine

Press release from: SA-BRC

Market Research on Anesthesia Drugs Market 2016 and Analysis

Anesthesia is a condition in which there is a reversible blockage in the electrical and chemical signals that passes information to the brain, resulting in loss of sensation. Medications known to result anesthesia are called anesthetics. Anesthetics are commonly used to facilitate medical and surgical procedures in order to prevent discomfort and pain. The major end-points (effects) that are expected to be achieved through anesthetics are unconsciousness, amnesia, analgesia and muscle relaxation. Several drugs may be needed in combination if the goal is to achieve multiple end points at the same time or in stages. Anesthesia has several risks and complications associated with it such as pulmonary distress, heart attack, pulmonary embolism along with minor risks such as post operative nausea and vomiting or PONV. There is currently a significant shortage of anesthetics in several parts of the world. The American Association of Anesthesiologists (ASA) noted a considerable shortage of vital anesthetic drugs such as propofol, succinylcholine, even epinephrine in the past few years.

There are two types of drugs namely, local anesthetic and general anesthetic. Local anesthesia is delivered to block pain in a specific body part, generally used for dental treatment, stitching, skin biopsies and several minimally invasive procedures. On the other hand the use of general anesthesia includes more extensive surgical procedures. Several advantages offered by general anesthesia are control of the body process mainly respiratory and circulatory system allows motionless for long duration during surgery and allows operation on different body parts at a time.

Click For Full Report And Request TOC@

The rise in number of surgeries, aging population and use in pediatrics are the key drivers for the global anesthesia drugs market. U.S.A alone contributes around US$ 3.5 billion market. Around 60-70% of the market share is of intravenous anesthetic in the U.S. market. Diprivan (Propofol) from Astra Zeneca, Lusedra (fospropofol disodium) from Eisai Co. ltd., SUPRANE (desflurane, USP) and AERRANE (isoflurane, USP) from Baxter are few of the top leading brands. Ketamine is an anesthetic drug reported to be one of the long time existing drugs in the market. JHP Pharma offers a branded generic of ketamine known as Ketalar, which remains the top selling brand among general anesthesia. Anesthetics drugs market largely consist of major pharmaceutical companies, niche pain management and generic anesthesia drugs suppliers. Top leading players in anesthesia drugs market are Baxter, Abott Laboratories, AstraZeneca PLC, Eisai Co. Ltd following Claris Life Sciences, Merck and Co., Celgene Corporation, Roche Diagnostics and Piramal Healthcare. Merck is currently struggling to introduce sugammadex facing a third rejection by the FDA.

With the increasing demand of anesthetic drugs in the market worldwide, most of the companies R&D (Research & Development) activities are focused on reducing number of side effects associated with existing anesthetic drugs. Several gender based anesthesia drugs are also being introduced in to the market to cater challenges physiologically linked with both sexes.

For More Research Reports@

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Market Research on Anesthesia Drugs Market 2016 and Analysis to 2020 here

News-ID: 400186 • Views: 311

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases

More Releases for Anesthesia

Anesthesia Monitoring Devices Market
Anesthesia Monitoring Devices Market was valued at USD 1035 Million in 2016 and is expected to reach USD 3272 Million by 2026, at a CAGR of 12.2%.(Detailed analysis of the market CAGR is provided in the report)Anesthesia Monitoring Devices MarketThe use of anesthesia monitoring device is to monitor a patient’s response towards anesthetic drugs during a surgery procedure. The Market for anesthesia monitoring devices primarily depends on increasing life expectancy
Anesthesia Drugs Market 2018 | Expected to Reach USD 4.9 Billion with Key Type A …
Market research future Publish a Prime Research Report on Global Anesthesia Drugs Market. The Global Market for Anesthesia Drugs Market is Growing Continuously and Expected to Grow at a CAGR of 3.7% from 2015 to 2022 Anesthesia Drugs Market - Overview Market Research Future (MRFR) has published a research report that presumes success for the global anesthesia drugs market with 3.7% CAGR (Compound Annual Growth Rate) between 2015 and 2022. In terms
Anesthesia Drugs Market Structure 2018 to 2023 | Expected to Reach USD 4.9 Billi …
“Anesthesia Drugs Market” Based on Various Factors - Price Analysis, Supply Chain Analysis, Porters five Force Analysis etc. and also Insights about Factors Affecting the Market Growth – Outlook Till 2023 Anesthesia Drugs Market - Segmentation         The global anesthesia drugs market has been segmented on the basis of route of administration, types of anesthesia, types of drugs, and lastly, region. On the basis of route of administration, this market has been
Anesthesia Machines Market Overview Till 2018-2023
Future Market Reports on Global Anesthesia Machines 2018 Research Report presents a professional and complete analysis of Global Anesthesia Machines Market on the current market situation. The Global Anesthesia Machines Market 2018 report includes Anesthesia Machines market Revenue, market Share, Anesthesia Machines industry volume, market Trends, Growth aspects. It analyses the important factors of the Anesthesia Machines market based on present industry situations, Anesthesia Machines market demands, business strategies utilized
Global Anesthesia Drugs Market Research Report 2017
The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with you. Request Sample Copy of the Business Report @ Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Anesthesia Drugs in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast
Anesthesia Machines Market: Very Useful devices
The global anesthesia machines market was valued at $1,315 million in 2016, and is expected to reach $2,168 million by 2025, registering a CAGR of 5.9% during 2017-2025. Anesthesia machines are devices used to deliver anesthesia to patients during a medical procedure. Over the years, these machines have undergone continuous developments ranging from a simple pneumatic device to a complex set of electrical, mechanical, and computer-controlled components. Some of the